XPONANCE, INC. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$224,783
-16.7%
14,164
-0.9%
0.00%
-25.0%
Q2 2023$269,690
+472.6%
14,292
+16.5%
0.00%
+300.0%
Q1 2023$47,098
-22.6%
12,2650.0%0.00%0.0%
Q4 2022$60,834
+4.9%
12,265
+1.5%
0.00%0.0%
Q3 2022$58,000
+11.5%
12,080
+4.2%
0.00%0.0%
Q2 2022$52,000
+6.1%
11,594
+13.5%
0.00%0.0%
Q1 2022$49,000
-29.0%
10,216
-2.6%
0.00%0.0%
Q2 2021$69,00010,4940.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders